(Circulation. 2003;107:e64.)
© 2003 American Heart Association, Inc.
Correspondence |
Anatomical Pathology, College of Medicine, Room 2106 Weiskotten Hall, SUNY Upstate Medical University, 750 East Adams St, Syracuse, NY 13210, hellstrr@mail.upstate.edu
To the Editor:
Rioufol et al1 recently reported a lower incidence of plaque rupture in culprit arteries than in non-culprit arteries (37.5% versus 79%) in acute coronary syndrome (ACS). The low incidence in culprit arteries was explained by thrombi that masked underlying ulcerations, but findings suggest that plaque rupture/thromboses do not directly induce symptoms in ACS (or ACS/infarction).
There are other problems with the plaque rupture/thromboses mechanism. These include low (around 25%) incidences of thromboses in ACS,2,3 failure of thrombolysis to benefit non-ST-segment elevation infarction,3 rising incidence of thromboses over time in infarction,2,3 common occurrence of asymptomatic plaque rupture,3 failure of platelet glycoprotein IIb/IIIa receptor blockade to benefit most cases of ACS,4 and apparent inability of thromboses in very stenotic arteries to explain infarction.2,3
To my knowledge, nobody has seen plaque rupture directly cause ACS. ACS is attributed to plaque rupture because of the association of plaque rupture with ACS, but this is only evidence consistent with this mechanism. Findings as rising incidences of thromboses in infarction seem to be inconsistent with ACS due directly to plaque rupture/thromboses, and such findings raise the possibility of falsifying this mechanism.
The mechanism of plaque rupture/thromboses was threatened by the finding that statins significantly reduced the incidence of infarction in the absence of significant improvement in coronary artery disease (CAD), and stabilization of "vulnerable" plaques provided an explanation for this apparent discrepancy.2,3 Although rupture of vulnerable plaques is accepted overwhelmingly, this explanation is also only consistent with the validity of the plaque rupture mechanism. The spasm of resistance vessel (S-RV) concept,5 which asserts that S-RV directly induces symptoms in ACS, offers another explanation for the action of statins in preventing infarction; statins, which are anti-spastic,2,3 operate basically by reducing the tendency toward S-RV.
The S-RV concept asserts that risk factors operate by causing S-RV, and the major risk factor of stenotic CAD is considered to cause S-RV through ischemic injury (ischemic injury-induced S-RV or ischemia-induced S-RV). The concept avers that plaque rupture in culprit arteries favors ACS mainly through stenoses; consistent with this, plaque rupture in the study by Rioufol et al1 was significantly more stenotic in culprit than in non-culprit arteries (70% versus 39%). Platelets probably play only a minor role in most cases of ACS,5 and operate mainly by release of vasoconstrictors.5 In addition to antiplatelet therapy for ACS, consideration should be given to reversing ischemia-induced S-RV, for example by
-adrenergic blockade.5
References
1. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002; 106: 804808.
2. Hellstrom HR. Occlusions of epicardial arteries might not directly induce symptoms in ischemic heart disease. Med Hypotheses. 1999; 53: 533542.[CrossRef][Medline] [Order article via Infotrieve]
3. Hellstrom HR. Plaque rupture and consequent thromboses probably do not cause acute coronary syndromes. Med Hypotheses. 2003; 60: 2635.[CrossRef][Medline] [Order article via Infotrieve]
4. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 1999; 340: 16231629.
5. Hellstrom HR. Can the premises of the spasm of resistance vessel concept permit improvement in the treatment and prevention of ischemic heart disease? Med Hypotheses. 2003; 60: 3651.[CrossRef][Medline] [Order article via Infotrieve]
Department of Hemodynamics, Cardiovascular Hospital, B.P Lyon-Monchat, 69394 Lyon Cedex 03, France, gilles.rioufol@univ-lyon1.fr
Dr Hellstrom raises the interesting physiopathological hypothesis that coronary microcirculation may play a fundamental spastic role in the genesis of acute coronary syndrome (ACS). He considers the presence of ruptured atherosclerotic plaque accompanied by culprit artery thrombus as an epiphenomenon that may promote and maintain the spasm of resistance vessel (S-RV) phenomenon via the stenosis caused. These ideas, however, fail to convince us for a number of reasons:
Atherothrombosis is a complex multi-factor condition with stochastic evolution; it therefore appears difficult to tie it down to just one dominant theory, even one focusing on microcirculation.
References
1. Ambrose JA, Winters SL, Arora RR, et al. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol. 1986; 7: 472478.[Abstract]
2. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol. 2000; 35: 106111.
3. Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002; 347: 512.
4. Sun H, Mohri M, Shimokawa H, et al. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol. 2002 Mar 6; 39 (5): 84751.
5. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002; 106: 804808.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |